Nanobiotix ADRs Jump Over 50% After Agreement With J&J’s Janssen Pharmaceutical
- Investing News
admin
- 0
- 1 minute read
American depositary receipts of Nanobiotix jumped over 50% in early trading on Monday after signing an agreement with J&J’s Janssen Pharmaceutical to work on co-developing a drug to treat head and neck cancer tumors.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1803777103-b9626d35c9fd4424ae7ecc3b6d58a558.jpg "Accountant Career Path and Qualifications")
:max_bytes(150000):strip_icc():format(jpeg)/AFFLUENT.MILLENNIAL.HERO.GettyImages-868506558_2600-84706e45802340b1865d4b49c285a662.jpg "The Affluent Millennial Investing Survey")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2151279555-f38549a64433496982ff93944b309afb.jpg "5 Transamerica Mutual Funds to Consider")
